Cargando…
Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target
The TMPRSS2–ERG gene fusion and subsequent overexpression of the ERG transcription factor occurs in ∼50% of prostate tumors, making it the most common abnormality of the prostate cancer genome. While ERG has been shown to drive tumor progression and cancer-related phenotypes, as a transcription fact...
Autores principales: | Greulich, Benjamin M, Plotnik, Joshua P, Jerde, Travis J, Hollenhorst, Peter C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848947/ https://www.ncbi.nlm.nih.gov/pubmed/33554122 http://dx.doi.org/10.1093/narcan/zcaa046 |
Ejemplares similares
-
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2
por: Plotnik, Joshua P., et al.
Publicado: (2017) -
4296 Targeting ERG Through Toll-Like Receptor 4 in Prostate Cancer
por: Greulich, Ben, et al.
Publicado: (2020) -
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
por: Plotnik, Joshua P., et al.
Publicado: (2014) -
Androgen signaling connects short isoform production to breakpoint formation at Ewing sarcoma breakpoint region 1
por: Nicholas, Taylor R, et al.
Publicado: (2021) -
Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines
por: Nhili, Raja, et al.
Publicado: (2013)